GILD

Investing

Try This ETF Pair to Round Out Biotech Exposure

By David DierkingMarch 23, 2018

Equity ETFs

A Biotech Pullback Could be Afoot

By Brenton GarenOctober 26, 2017

Equity ETFs

Biotech ETFs Remain Bell of the Ball

By Brenton GarenSeptember 1, 2017

Equity ETFs

September Could be Kind to Biotechnology ETFs

By Brenton GarenAugust 29, 2017

Equity ETFs

Biotech ETFs Jump on Gilead, Kite Deal

By Max ChenAugust 28, 2017

Equity ETFs

For Biotech ETFs, It’s All About U.S. Presidential Politics

By Tom LydonSeptember 1, 2016

Equity ETFs

Pfizer Acquires Medivation, Renews Biotech M&A Bets

By Max ChenAugust 22, 2016

Equity ETFs

Reading Market Tea Leaves With a Big Biotech ETF

By Tom LydonAugust 10, 2016

Equity ETFs

Amid Biotech Rally, Investors Show Jitters

By Tom LydonAugust 4, 2016

Equity ETFs

Surprising Value in Big Biotech ETFs

By Brenton GarenJuly 21, 2016